vTv Therapeutics (VTVT) Receivables (2015 - 2024)
vTv Therapeutics' (VTVT) quarterly Receivables came in at $62000.0 in Q4 2024, down 39.22% year-on-year from $102000.0 in Q1 2024, and down 74.38% quarter-over-quarter from $242000.0 in Q3 2024.
vTv Therapeutics (VTVT) Receivables (2015 - 2024) Analysis & Trends
vTv Therapeutics has disclosed Receivables across 10 years of filings, most recently posting $62000.0 for Q4 2024.
- Receivables for Q4 2024 came in at $62000.0, down 39.22% year-over-year; the trailing twelve-month figure through Dec 2024 was $62000.0 (down 39.22% YoY), and the FY2024 annual result was $62000.0, down 39.22% from the prior year.
- Receivables came in at $62000.0 for Q4 2024 at vTv Therapeutics, down from $242000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $12.5 million in Q3 2022 to a low of $2000.0 in Q1 2021.
- The 5-year median for Receivables is $102000.0 (2023), against an average of $1.0 million.
- Peak annual rise in Receivables reached 6528.57% in 2021, while the deepest fall reached 63.92% in 2021.
- vTv Therapeutics' Receivables stood at $158000.0 in 2020, then tumbled by 63.92% to $57000.0 in 2021, then surged by 203.51% to $173000.0 in 2022, then plunged by 41.04% to $102000.0 in 2023, then sank by 39.22% to $62000.0 in 2024.
- The last three Receivables figures came in at $62000.0 (Q4 2024), $242000.0 (Q3 2024), and $306000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 242,000.00 |
| Jun 30, 2024 | 306,000.00 |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 77,000.00 |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 1.82 Mn |
| Mar 31, 2018 | 210,000.00 |
| Dec 31, 2017 | 8.00 Mn |